​

We specialize in API delivery technologies and offer three distinct

Patent-Pending systems to give you the ability to design your products as pharmaceutical API delivery systems. All nanoQuick types are fully-tunable Patent-Pending, Self-Emulsifying Drug Delivery System (SEDDS) solutions that improve the solubility, micelle stability, enhances the absorption potential, and increases the bio-availability ofthe API using food-grade ingredients and lab-tested processes. monarQh

addresses the primary methods of API absorption in the body via three formulations:

​

nanoQuick S: Sublingual and Transdermal delivery

​

nanoQuick S is not an emulsion, it is a true water-soluble pharma-grade drug delivery system that does not utilize an oil formula so it can be used as a sublingual or transdermal (with a carrier agent). NanoQuick S creates stable nano-particle sized water-soluble micellar colloidal suspension for cannabinoids and other water insoluble APIs.

 

Finished format: APIs suspended in water

Bloodstream absorption potential: 90%+

Particle Size: 10-30 Nanometers

Best Applications: Beverages, some gummy formulations and edibles that rely on a water phase as part of the finished product.

​

nanoQuick L: Lymphatic delivery

​

nanoQuick L is a patent-pending system that addresses the entire Lymphatic Transport System (“LTS”) and utilizes carrier oils supporting the LTS as part of the system. NanoQuick L is designed to bypass the Hepatic Transport System that also includes the first-pass liver metabolism stage so the API isn’t subjected to enzyme API conversion.

 

Finished format: APIs suspended in nanoQuick L carrier oils 

Bloodstream absorption potential: 80%+

Micelle Size: 50-100 Nanometers

Best Applications: Edibles including Gummies, Beverages (when utilizing and external emulsification stage).

​

nanoQuick H: Hepatic delivery

​

nanoQuick H is a patent-pending system that addresses the entire Hepatic Transport System (“HTS”) and utilizes carrier oils supporting the HTS as part of the system. NanoQuick H is designed to support the HTS that also includes the first-pass liver metabolism stage so the API is subjected to enzyme API conversion.

​

Finished format: APIs suspended in nanoQuick H carrier oils

Bloodstream absorption potential: 70%+ ( original and converted API)

Micelle Size: 50-100 Nanometers

Best Applications: Edibles including Gummies, Beverages (when utilizing and external emulsification stage).

​

​